2023
DOI: 10.1007/s12274-023-5646-6
|View full text |Cite
|
Sign up to set email alerts
|

Tannic acid assisted anti-TNF-α nanobody assembly modulating the epithelial barrier dysregulation of allergic rhinitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…This cascade triggers Th2 cell-mediated allergic responses and leads to the release of chemoattractant eotaxin-1 (CCL11) (29). Another study combined an anti-TNF-a nanobody (V) with tannic acid (V/ TA) as a functional antibody drug candidate and found that it could inhibit cytokine release in an ovalbumin (OVA)-induced AR murine model (30). In our study, the observed association between elevated levels of TNF-a and increased AR risk aligns with previous research findings.…”
Section: Discussionmentioning
confidence: 99%
“…This cascade triggers Th2 cell-mediated allergic responses and leads to the release of chemoattractant eotaxin-1 (CCL11) (29). Another study combined an anti-TNF-a nanobody (V) with tannic acid (V/ TA) as a functional antibody drug candidate and found that it could inhibit cytokine release in an ovalbumin (OVA)-induced AR murine model (30). In our study, the observed association between elevated levels of TNF-a and increased AR risk aligns with previous research findings.…”
Section: Discussionmentioning
confidence: 99%